| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,384,065 |
|
|
|
Indirect Value
|
$4,253,337 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,637,402 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 14 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-04 |
4 |
AS |
$22.19 |
$168,614 |
I/I |
(7,600) |
84,225 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-08-01 |
4 |
AS |
$27.47 |
$211,629 |
I/I |
(7,704) |
238,059 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-09-01 |
4 |
AS |
$28.08 |
$216,328 |
I/I |
(7,704) |
230,355 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-10-03 |
4 |
AS |
$26.77 |
$209,296 |
I/I |
(7,704) |
222,651 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-11-01 |
4 |
AS |
$25.43 |
$196,386 |
I/I |
(7,704) |
214,947 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-12-01 |
4 |
AS |
$23.95 |
$184,503 |
I/I |
(7,704) |
207,243 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-01-03 |
4 |
AS |
$22.82 |
$176,316 |
I/I |
(7,704) |
199,539 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-02-09 |
4 |
AS |
$93.99 |
$823,706 |
I/I |
(8,500) |
366,494 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
8,523 |
27,287 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,636 |
13,291 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-09 |
4 |
AS |
$46.33 |
$411,856 |
I/I |
(8,852) |
115,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-10 |
4 |
AS |
$44.42 |
$402,451 |
I/I |
(8,852) |
112,562 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-22 |
4 |
AS |
$38.65 |
$345,368 |
I/I |
(8,852) |
110,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-23 |
4 |
AS |
$38.97 |
$347,350 |
I/I |
(8,852) |
107,562 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-14 |
4 |
AS |
$37.10 |
$338,221 |
I/I |
(8,852) |
105,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-15 |
4 |
AS |
$36.29 |
$323,671 |
I/I |
(8,852) |
102,562 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-29 |
4 |
AS |
$44.81 |
$401,129 |
I/I |
(8,852) |
100,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-30 |
4 |
AS |
$44.04 |
$397,680 |
I/I |
(8,852) |
97,562 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-09-12 |
4 |
OE |
$6.88 |
$61,909 |
D/D |
9,005 |
51,345 |
|
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2019-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
9,036 |
51,323 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-04-04 |
4 |
AS |
$21.45 |
$196,310 |
I/I |
(9,152) |
22,789 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-08-18 |
4 |
AS |
$60.59 |
$572,768 |
I/I |
(9,356) |
147,804 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
• – – |
2007-11-16 |
4 |
OE |
$14.28 |
$134,884 |
I/I |
9,445 |
47,417 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-01 |
4 |
AS |
$20.06 |
$191,425 |
I/I |
(9,545) |
54,525 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-02-06 |
4 |
AS |
$23.63 |
$232,685 |
I/I |
(9,847) |
34,590 |
0 |
- |
|
424 Records found
|
|
Page 14 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
